Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Alexandra Clarissa Bayer"'
Autor:
Jessy Etienne, Pierre Joanne, Cyril Catelain, Stéphanie Riveron, Alexandra Clarissa Bayer, Jérémy Lafable, Isabel Punzon, Stéphane Blot, Onnik Agbulut, Jean‐Thomas Vilquin
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 4, Pp 1047-1069 (2020)
Abstract Background Aldehyde dehydrogenases (ALDHs) are key players in cell survival, protection, and differentiation via the metabolism and detoxification of aldehydes. ALDH activity is also a marker of stem cells. The skeletal muscle contains popul
Externí odkaz:
https://doaj.org/article/f56c13a40fb94475b9f3b72a640ea42e
Publikováno v:
Frontiers in Neurology, Vol 10 (2019)
Myasthenia gravis (MG) is a rare autoimmune disease mediated by pathogenic antibodies (Ab) directed against components of the neuromuscular junction (NMJ), mainly the acetylcholine receptor (AChR). The etiological mechanisms are not totally elucidate
Externí odkaz:
https://doaj.org/article/f0804a302ce84f34ada0b2026f8ba257
Autor:
Cyril Catelain, Stéphane Blot, Pierre Joanne, Jean-Thomas Vilquin, Onnik Agbulut, Jessy Etienne, Isabel Punzón, Stéphanie Riveron, Jérémy Lafable, Alexandra Clarissa Bayer
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, 2020, 11, pp.1047-1069. ⟨10.1002/jcsm.12557⟩
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 4, Pp 1047-1069 (2020)
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, 2020, 11 (4), pp.1047-1069. ⟨10.1002/jcsm.12557⟩
Journal of Cachexia, Sarcopenia and Muscle, 2020, 11 (4), pp.1047-1069. ⟨10.1002/jcsm.12557⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, 2020, Epub ahead of print. ⟨10.1002/jcsm.12557⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, 2020, 11, pp.1047-1069. ⟨10.1002/jcsm.12557⟩
Journal of Cachexia, Sarcopenia and Muscle, Vol 11, Iss 4, Pp 1047-1069 (2020)
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, 2020, 11 (4), pp.1047-1069. ⟨10.1002/jcsm.12557⟩
Journal of Cachexia, Sarcopenia and Muscle, 2020, 11 (4), pp.1047-1069. ⟨10.1002/jcsm.12557⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, 2020, Epub ahead of print. ⟨10.1002/jcsm.12557⟩
International audience; BACKGROUND:Aldehyde dehydrogenases (ALDHs) are key players in cell survival, protection, and differentiation via the metabolism and detoxification of aldehydes. ALDH activity is also a marker of stem cells. The skeletal muscle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38e16b97ee33d7d7fdbea1003a2b3867
https://hal.archives-ouvertes.fr/hal-02518437
https://hal.archives-ouvertes.fr/hal-02518437
Autor:
Jacky Bismuth, Nicola Santelmo, Katia Ider, Nadine Dragin, Frédérique Truffault, José Villegas, Régine Roussin, Rozen Le Panse, Alexandra Clarissa Bayer, Sonia Berrih-Aknin
Publikováno v:
Journal of Autoimmunity
Journal of Autoimmunity, 2019, 98, pp.59-73. ⟨10.1016/j.jaut.2018.11.005⟩
Journal of Autoimmunity, Elsevier, 2019, 98, pp.59-73. ⟨10.1016/j.jaut.2018.11.005⟩
Journal of Autoimmunity, 2019, 98, pp.59-73. ⟨10.1016/j.jaut.2018.11.005⟩
Journal of Autoimmunity, Elsevier, 2019, 98, pp.59-73. ⟨10.1016/j.jaut.2018.11.005⟩
IL-23/Th17 pathway has been identified to sustain inflammatory condition in several autoimmune diseases and therefore being targeted in various therapeutic and effective approaches. Patients affected with autoimmune myasthenia gravis exhibit a diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fd10fc15eafe25470e58964dfaaaaee
https://hal.archives-ouvertes.fr/hal-02357775
https://hal.archives-ouvertes.fr/hal-02357775
Publikováno v:
HAL
Frontiers in Neurology
Frontiers in Neurology, Frontiers, 2020, 10, pp.1343
Frontiers in Neurology, Vol 10 (2019)
Frontiers in Neurology, 2020, 10, pp.1343
Frontiers in Neurology
Frontiers in Neurology, Frontiers, 2020, 10, pp.1343
Frontiers in Neurology, Vol 10 (2019)
Frontiers in Neurology, 2020, 10, pp.1343
International audience; Myasthenia gravis (MG) is a rare autoimmune disease mediated by pathogenic antibodies (Ab) directed against components of the neuromuscular junction (NMJ), mainly the acetylcholine receptor (AChR). The etiological mechanisms a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65229a28f9d9c6a5300d889f741f2487
https://hal.archives-ouvertes.fr/hal-02396099
https://hal.archives-ouvertes.fr/hal-02396099